regulatory approval

News

Tenpoint eyes presbyopia drug launch after FDA nod

Tenpoint is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis, and LENZ with a dual-acting rival.

News

China clears its first drug for chronic hepatitis D

Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus.

News

EU approves Otsuka's long-acting HAE drug Dawnzera

An EMA nod for Otsuka's Dawnzera offers EU patients with HAE a drug that can be self-administered by patients with up to eight weeks between doses.

News

Sentynl gets first FDA approval for rare disease Menkes

Children with a devastating, rare disorder of copper metabolism, called Menkes disease, now have an FDA-approved treatment for the first time.

News

Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer

Hengrui has achieved a milestone in oncology as retlirafusp alfa is approved in China, its first world market, for gastric cancer.

News

China clears GSK's Nucala for COPD

GSK has unlocked a big new market for Nucala for COPD - China - which accounts for around a quarter of the global patient population.

Tenpoint eyes presbyopia drug launch after FDA nod

China clears its first drug for chronic hepatitis D

EU approves Otsuka's long-acting HAE drug Dawnzera

Sentynl gets first FDA approval for rare disease Menkes

Hengrui gets first OK for a PD-L1/TGF-beta drug for cancer

China clears GSK's Nucala for COPD

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

regulatory approval

Editor's Picks